Drugs / NK Cell Infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00383994 | Sep 2006 → Jul 2019 | disease related to transplantation, leukemia, lymphoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NK Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00383994 ↗ |
| Modality | Cell therapy | “a boost of natural killer (NK) cells from a donor” NCT00383994 ↗ |
| Route | Intravenous | “These cells will be infused through a vein” NCT00383994 ↗ |